Company: PMVP
Filing Date: 2025-04-25
Form Type: DEF 14A
Source: 0001140361-25-015610
Chunk: 28

Company: PMV Pharmaceuticals, Inc.
Filing Date: 2025-04-25
Form: DEF 14A
Chunk 28
---
,101 |
| Kirsten Flowers              |     |       47,500 |     | —          |     |       81,032 |     | —                |     | —            |     | —                |     |   128,532 |
| Carol Gallagher, Pharm.D.    |     |       44,000 |     | —          |     |       81,032 |     | —                |     | —            |     | —                |     |   125,032 |
| Arnold Levine, Ph.D.         |     |       40,000 |     | —          |     |       81,032 |     | —                |     | —            |     | 100,000(3)       |     |   221,032 |
| Laurie Stelzer               |     |       60,000 |     | —          |     |       81,032 |     | —                |     | —            |     | —                |     |   141,032 |

| (1) | In June 2024, in addition to the annual option grant award under our “Outside Director Compensation Policy”, each continuing non-employee director received a one-time special award of 45,000 stock options, which vest in equal monthly installments over three years. |

| (2) | Dr. Baum received annual compensation of $87,069 pursuant to a consulting agreement. For additional information regarding our consulting agreement with Dr. Baum, see “Certain Relationships and Related Person Transactions—Consulting Agreement with Charles M. Baum, M.D., Ph.D.” |

| (3) | Dr. Levine received annual compensation of $100,000 pursuant to a consulting agreement. For additional information regarding our consulting agreement with Dr. Levine, see “Certain Relationships and Related Person Transactions—Consulting Agreement with Arnold Levine, Ph.D.” |

16

TABLE OF CONTENTS

The following table lists all outstanding equity awards held by non-employee directors as of December 31, 2024.

| Name                         |     | Number of Shares 
 Underlying       
 Outstanding      
 Stock Awards     |     |    Number of Shares 
          Underlying 
 Outstanding Options |
| Richard Heyman, Ph.D.        |     | —                |     |             370,758 |
| Charles M. Baum, M.D., Ph.D. |     | —                |     |             154,338 |
| Kirsten Flowers              |     | —                |